Danielle Bruce, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3120 Rider Trl S, Earth City, MO 63045 Phone: 314-702-4036 Fax: 314-702-4156 |
News Archive
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced the completion of patient enrollment in two randomized, double-masked, Phase 3 clinical trials evaluating VEGF Trap-Eye in the treatment of the neovascular form of age-related macular degeneration (wet AMD).
A new study conducted by Brigham and Women's Hospital and Harvard Medical School shows that increased intake of fish reduces the symptoms of rheumatoid arthritis. The study has found reduced levels of arthritis in people who consumed fish twice or more than twice a week, compared with people who never consumed fish or consumed it less than once in a month.
Cubist Pharmaceuticals, Inc. today announced that a trial date has been set for patent litigation in the U.S. District Court for the District of Delaware against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. alleging infringement of Cubist's US Patent Nos. 6,468,967 and 6,852,689, which expire on September 24, 2019, and US Patent No. RE39,071, which expires on June 15, 2016.
Relatively few people are aware of the health benefits of mushrooms, according to a new national survey by University of Florida Institute of Food and Agricultural Sciences researchers.
With the COVID-19 pandemic continuing to spread around the globe, Scripps Research has quickly established an international network of collaborating scientific laboratories to leverage ReFRAME, the world's leading drug repurposing collection, to find antiviral compounds against the novel coronavirus.
› Verified 2 days ago